Design and synthesis of a novel series of matrix metalloproteinase inhibitors with high selectivity for MMP-3.

被引：0
|
作者：
Dack, KN [1 ]
Dickinson, RP [1 ]
Lewis, ML [1 ]
Whitlock, GA [1 ]
机构：
[1] Pfizer Global Res & Dev, Discovery Chem, Sandwich, Kent, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 222卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
260-MEDI
引用
收藏
页码：U684 / U684
页数：1
相关论文
共 50 条
  • [41] Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors
    Nuti, Elisa
    Panelli, Laura
    Casalini, Francesca
    Avramova, Stanislava I.
    Orlandini, Elisabetta
    Santamaria, Salvatore
    Nencetti, Susanna
    Tuccinardi, Tiziano
    Martinelli, Adriano
    Cercignani, Giovanni
    D'Amelio, Nicola
    Maiocchi, Alessandro
    Uggeri, Fulvio
    Rossello, Armando
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (20) : 6347 - 6361
  • [42] Significance of matrix metalloproteinase 9 (MMP-9) and matrix metalloproteinase 3 (MMP-3) expression during liver metastasis in colorectal cancer
    Inuzuka, K
    Ogata, Y
    Ohkita, A
    Konishi, J
    Oda, H
    Harada, Y
    Hara, Y
    Kanazawa, M
    Shirouzu, K
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 740 - 740
  • [43] Study of Matrix Metalloproteinase (MMP) and Tissue Inhibitors of Metalloproteinase (TIMP) Gene Polymorphisms in Renal Allograft Outcome
    Tom, J. P.
    Singh, J.
    Sharma, A.
    Aggarwal, R.
    Nada, R.
    Ramachandran, R.
    Anand, S.
    Minz, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 748 - 748
  • [44] Design and Synthesis of Triple-Helical, Transition State Analog Matrix Metalloproteinase Inhibitors
    Bhowmick, Manishabrata
    Lepore, Salvatore
    Fields, Gregg B.
    BIOPOLYMERS, 2011, 96 (04) : 467 - 467
  • [45] Design and synthesis of fluorine-18 labeled matrix metalloproteinase inhibitors for cancer imaging
    Furumoto, S
    Iwata, R
    Ido, T
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2002, 45 (11): : 975 - 986
  • [46] Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors
    Choi, Jun Yong
    Fuerst, Rita
    Knapinska, Anna M.
    Taylor, Alexander B.
    Smith, Lyndsay
    Cao, Xiaohang
    Hart, P. John
    Fields, Gregg B.
    Roush, William R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5816 - 5825
  • [47] Design, Synthesis and Biological Evaluation of Ferulic Acid Amides as Selective Matrix Metalloproteinase Inhibitors
    Shi, Zhi-Hao
    Li, Nian-Guang
    Shi, Qian-Ping
    Hao-Tang
    Tang, Yu-Ping
    Wei-Li
    Lian-Yin
    Yang, Jian-Ping
    Duan, Jin-Ao
    MEDICINAL CHEMISTRY, 2013, 9 (07) : 947 - 954
  • [48] The design, structure, and therapeutic application of matrix metalloproteinase inhibitors
    Skiles, JW
    Gonnella, NC
    Jeng, AY
    CURRENT MEDICINAL CHEMISTRY, 2001, 8 (04) : 425 - 474
  • [49] An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present)
    Banerjee, Suvankar
    Baidya, Sandip Kumar
    Adhikari, Nilanjan
    Jha, Tarun
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2023, 33 (10) : 631 - 649
  • [50] Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents
    Belo, Vanessa A.
    Souza-Costa, Debora C.
    Lana, Carla M.
    Caputo, Fabio L. D.
    Marcaccini, Andrea M.
    Gerlach, Raquel F.
    Bastos, Marcus G.
    Tanus-Santos, Jose E.
    CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) : 984 - 990
12345